Location · Peoria, IL
Clinical trials in Peoria, IL
31 recruiting studies have a site in Peoria, and 8 of them accept healthy volunteers.
31 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Peoria, IL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 3
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
GlaxoSmithKline
- Location
- Peoria, IL + 130 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Sanofi
- Location
- Peoria, IL + 70 other US sites
- Eligibility basics
- Ages 40–80
- Recruiting
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Apreo Health, Inc.
- Location
- Peoria, IL + 17 other US sites
- Eligibility basics
- Ages 40–84
- RecruitingPhase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Alnylam Pharmaceuticals
- Location
- Peoria, IL + 213 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
AstraZeneca
- Location
- Peoria, IL + 93 other US sites
- Eligibility basics
- Ages 18–130
- RecruitingPhase 2
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Edgewise Therapeutics, Inc.
- Location
- Peoria, IL + 3 other US sites
- Eligibility basics
- Ages 30–84
- RecruitingPhase 2/Phase 3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Alkermes, Inc.
- Location
- Peoria, IL + 32 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
Octapharma
- Location
- Peoria, IL + 4 other US sites
- Eligibility basics
- Ages 12–80
- RecruitingPhase 2
Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels
Vifor Pharma, Inc.
- Location
- Peoria, IL + 9 other US sites
- Eligibility basics
- Ages 0 mo–11
- RecruitingPhase 2
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
AbbVie
- Location
- Peoria, IL + 53 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Pulmonx Corporation
- Location
- Peoria, IL + 17 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
Amgen
- Location
- Peoria, IL + 2 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 2/Phase 3
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
DiaMedica Therapeutics Inc
- Location
- Peoria, IL + 35 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 3
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Takeda
- Location
- Peoria, IL + 9 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 2
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Cytokinetics
- Location
- Peoria, IL + 23 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 3
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Novo Nordisk A/S
- Location
- Peoria, IL + 129 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
PPD Development, LP
- Location
- Peoria, IL + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
PPD Development, LP
- Location
- Peoria, IL + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
PPD Development, LP
- Location
- Peoria, IL + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
PPD Development, LP
- Location
- Peoria, IL + 26 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Kardigan, Inc.
- Location
- Peoria, IL + 46 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Global Trial in APG2575 for Patients With CLL/SLL
Ascentage Pharma Group Inc.
- Location
- Peoria, IL + 10 other US sites
- Eligibility basics
- Ages 18–99
- Recruiting
Flow Detection in Open and Closed Shunt Valve Periods
Rhaeos, Inc.
- Location
- Peoria, IL
- Eligibility basics
- Any age listed